Monthly Archives: April 2024

Nattydread

A Potential Cure for Schizophrenia-Schizoaffective Disorders: Therapeutic Medical Cannabis, Indica Preferred

Medical Cannabis has been so stigmatized over the years. One of the few effective treatments for Schizophrenia and Schizoaffective phenotype of mental illness is, Therapeutic Medical Cannabis.

Prior to the war on drugs by President Richard Nixon, when he was trying to cover up the Watergate scandal, medical cannabis was used instead of Morphine for pain management. Today, medical cannabis is villified as the “gateway to illict drug use”.

Actually, medical cannabis is the “Oh, Oh, it’s magic” medicinal for behavioral health/mental health care. It has impressed me with it’s breadth of therapeutic effectiveness, and efficacy. I use it clinicallly, instead of Ozempic/Semaglutide drugs for weight loss, because, I can also treat the co-occurring behavioral health disorders, in tandem/simultaneously with Metabolic Syndrome. Therapeutic Medical Cannabis, is the best treatment for high blood pressure/hypertension, and high blood glucose/diabetes, secondary to improvement of the gut brain axis, cross talk, as well as, the hypothalamic-pituiatry-adrenal axis cross talk/communications.

In the future, mainly Therapeutic Medical Cannabis, and/or the Psychedelic medicinals will be first line therapeutics, as Psychiatric treatment modalities. Of note, there is intravenous/IV medical cannabis, which can be used in the field, in emergencies, when mental health crises are encountered.

It’s all hands on deck when it comes to the mental health crises in the United States, and the opioid epidemic in our youths. Behavioral Health Telemedicine in tandem with National Detoxification Acupuncture Association (NADA) protocol, and Battlefield with Trench Auricular Acupuncture protocols will revolutionalize behavioral health/mental health wellness/care nationally, as well as, globally.

Nattydread

Alcoholism: An Epidemic in Women’s Health

When I started treating hyposexual desire disorder (HSDD) in women with the pink pill, Addyi, I was shocked by how much women of childbearing age were drinking. They were consuming way more than 3 glasses of alcoholic beverages per week. When I tried to inform them that this was too much, and extremely cardiotoxic, I got an immense amount of push back.

Then COVID happened, and things got exponentially worse, now women are showing up in severe liver failure with hepatic alcholic steatosis in emergency rooms from acute alcoholic intoxication. Additionally, primary care clinicians are dealing with a surge in liver damage from the huge amount of alcohol that is consumed by women to self-medicate, keep them mellow, and I dare say, function, post pandemic.

We must use Telemedicine to increase comprehensive wrap around care in Women’s Health, and once there is a mild elevation in liver function test laboratories, such as, AST, ALT, GGPT, LDH and T. Bili, send the patient for a liver ultrasound, and or fibroscan. A MRI of the liver may be needed, even a MRCP, may be needed. Ultimately, a liver biopsy may have to be checked.

Ultimately, primary care physicians must currently be on high alert during clinical encounters, and perform a complete physical examnination, even with Telemedicine, which would be accomplished with a video consult, not just an audio consult. Also, the follow up on the diagnostic test results is of utmost critical and clinical importance, in the continuity of care in Women’s Health.